576 results
Page 4 of 29
8-K
EX-99.1
d2unlby4x 0vrj8kyqt
21 Dec 20
Ligand and GSK Enter Global Collaboration and License Agreement Leveraging Icagen’s Discovery Technology to Target Neurological Disorders
8:39am
8-K/A
EX-99.1
tajhboa4lht6usk7
10 Dec 20
Financial Statements and Exhibits
4:13pm
8-K
EX-3.1
uh64frbi70ui qkb23
30 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
EX-99.1
rdqlauu
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-2.1
3wzier43rlk7hyh22f
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
xcv5eh7tpxypr4sm 4s
1 Oct 20
Contingent Value Rights Agreement
8:42am
SC TO-T/A
mv62ak9ewfn6g8
11 Sep 20
Third party tender offer statement (amended)
6:07am
8-K
EX-10.4
5e8n fr5wwufd
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.2
dvw9 q6lb
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.3
0dw766dtuoswnhsd
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
6dfxm8z6fscvxtnpu
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
o7wj90aqibtls8nq7ed
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
9mfzgr34jru0qpnrw9zv
10 Aug 20
Information about tender offer
9:50pm
SC TO-C
EX-2.1
4cy3j8 1nwftzss8jrs
10 Aug 20
Information about tender offer
9:50pm
8-K
cnzxu
10 Aug 20
Tender and Support Agreement
9:48pm